The Board has approved a third interim dividend of INR 6 per equity share (60% on a face value of INR 10) for FY 2024-25, with a record date set for February 5, 2025. This dividend will be dispatched within 30 days of the declaration. Additionally, the Board noted the voluntary liquidation process of Suburban Diagnostics (India) Pvt. Ltd., aimed at consolidating its business with Dr. Lal PathLabs, enhancing operational efficiency and reducing administrative overheads.